Description
SLU-PP-332 is a synthetic estrogen-related receptor (ERR) agonist investigated as an exercise-mimetic research compound in energy-metabolism model systems.
What it is
SLU-PP-332 is a synthetic pan-ERR agonist investigated as an exercise-mimetic metabolic research compound in preclinical systems.
Mechanism snapshot
- Activates estrogen-related receptor transcriptional programs tied to oxidative metabolism.
- Investigated for acute endurance and aerobic-response signaling effects.
- Studied for metabolic syndrome biomarker changes in controlled preclinical models.
Research programs
- Skeletal-muscle metabolic pathway activation experiments.
- Exercise-capacity and endurance outcome modeling.
- Metabolic syndrome and energy-homeostasis translational preclinical studies.
Limitations
- Current literature base is early-stage and relatively small.
- Human safety/efficacy translation remains undefined.
- Mechanistic promise does not establish clinical utility.
Selected references
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome - PubMed 2024
- Synthetic ERRalpha/beta/gamma Agonist Induces an ERRalpha-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity - PubMed 2023
- Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRalpha/beta/gamma Agonist for Doping-Control Purposes - PubMed 2026
Ordering
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.



